News

Clinical Trials Arena8h

Eli Lilly’s Mounjaro shows cardiovascular gains, but analysts underwhelmed

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.
Clinical Trials Arena9h

Lantern Pharma concludes patient enrolment for trial of LP-300 in Japan

Lantern Pharma has completed targeted enrolment for its multi-centre Phase II HARMONIC trial of a disulfide small molecule, LP-300.